Clinical impact of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with resectable pancreatic cancer: diagnosing lymph node metastasis and predicting survival. [electronic resource]
- Nuclear medicine communications Jul 2018
- 691-698 p. digital
Publication Type: Journal Article
1473-5628
10.1097/MNM.0000000000000855 doi
Adult Aged Aged, 80 and over Disease-Free Survival Female Fluorodeoxyglucose F18 Humans Lymphatic Metastasis Male Middle Aged Pancreatic Neoplasms--diagnostic imaging Positron Emission Tomography Computed Tomography